Year |
Citation |
Score |
2021 |
Chung WM, Chen L, Chang WC, Su SY, Hung YC, Ma WL. Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials. International Journal of Molecular Sciences. 22. PMID 34299364 DOI: 10.3390/ijms22147748 |
0.447 |
|
2020 |
Lai HC, Chung WM, Chang CM, Liao PY, Su YT, Yeh CC, Jeng LB, Ma WL, Chang WC. Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness. Anticancer Research. 40: 1285-1295. PMID 32132025 DOI: 10.21873/anticanres.14070 |
0.352 |
|
2019 |
Yang JC, Chang N, Wu DC, Cheng WC, Chung WM, Chang WC, Lei FJ, Liu CJ, Wu IC, Lai HC, Ma WL. Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer. Journal of Cellular and Molecular Medicine. PMID 31557413 DOI: 10.1111/jcmm.14605 |
0.374 |
|
2019 |
Chung WM, Ho YP, Chang WC, Dai YC, Chen L, Hung YC, Ma WL. Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis. Cancers. 11. PMID 30986993 DOI: 10.3390/cancers11040463 |
0.349 |
|
2017 |
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 8: 74119-74128. PMID 29088772 DOI: 10.18632/oncotarget.18271 |
0.692 |
|
2017 |
Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. 8: 69508-69519. PMID 29050220 DOI: 10.18632/oncotarget.17843 |
0.785 |
|
2017 |
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. PMID 28618396 DOI: 10.18632/oncotarget.18271 |
0.692 |
|
2017 |
Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. PMID 28562322 DOI: 10.18632/oncotarget.17843 |
0.785 |
|
2016 |
Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C. Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals. International Journal of Cancer. PMID 27668844 DOI: 10.1002/Ijc.30446 |
0.491 |
|
2016 |
Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Cheng WC, Hsu CL, Cai X, Chang C, Ma WL. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget. PMID 27340775 DOI: 10.18632/Oncotarget.10186 |
0.722 |
|
2016 |
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib Plus NK Cells-Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. PMID 26939703 DOI: 10.1158/1535-7163.Mct-15-0706 |
0.583 |
|
2015 |
Chen YH, Chen CJ, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Tsai KS, Wu SY, Chang C, Chen HY, Yeh S. Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence. World Journal of Urology. PMID 25577129 DOI: 10.1007/S00345-014-1474-3 |
0.419 |
|
2014 |
Chen YH, Chen CJ, Yeh S, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Chang C, Chen HY. Urethral dysfunction in female mice with estrogen receptor β deficiency. Plos One. 9: e109058. PMID 25275480 DOI: 10.1371/Journal.Pone.0109058 |
0.439 |
|
2014 |
Hsu CL, Liu JS, Wu PL, Guan HH, Chen YL, Lin AC, Ting HJ, Pang ST, Yeh SD, Ma WL, Chen CJ, Wu WG, Chang C. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87. PMID 25091737 DOI: 10.1016/J.Molonc.2014.06.009 |
0.776 |
|
2014 |
Ma WL, Jeng LB, Lai HC, Liao PY, Chang C. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells. Cancer Letters. 351: 64-71. PMID 24944078 DOI: 10.1016/J.Canlet.2014.05.017 |
0.55 |
|
2014 |
Chang TY, Chung CY, Chuang WM, Li LY, Jeng LB, Ma WL. Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma. Biomed Research International. 2014: 156356. PMID 24734226 DOI: 10.1155/2014/156356 |
0.322 |
|
2014 |
Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer. 21: R165-82. PMID 24424503 DOI: 10.1530/Erc-13-0283 |
0.59 |
|
2014 |
Chen L, Chang WC, Hung YC, Chang YY, Bao BY, Huang HC, Chung WM, Shyr CR, Ma WL. Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line. Reproductive Sciences (Thousand Oaks, Calif.). 21: 386-94. PMID 23962788 DOI: 10.1177/1933719113497281 |
0.713 |
|
2013 |
Hsieh TF, Chen CC, Ma WL, Chuang WM, Hung XF, Tsai YR, Lin MH, Zhang Q, Zhang C, Chang C, Shyr CR. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation. Oncology Reports. 30: 2917-22. PMID 24126741 DOI: 10.3892/Or.2013.2792 |
0.768 |
|
2013 |
Chung WM, Chang WC, Chen L, Chang YY, Shyr CR, Hung YC, Ma WL. MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro. Stem Cell Research & Therapy. 4: 88. PMID 23890123 DOI: 10.1186/scrt247 |
0.63 |
|
2013 |
Chen CC, Hsieh TF, Chang CH, Ma WL, Hung XF, Tsai YR, Lin MH, Zhang C, Chang C, Shyr CR. Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2. Oncology Reports. 30: 979-85. PMID 23715826 DOI: 10.3892/Or.2013.2506 |
0.759 |
|
2013 |
Hsieh TF, Chen CC, Yu AL, Ma WL, Zhang C, Shyr CR, Chang C. Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cells. Oncology Letters. 5: 1325-1330. PMID 23599788 DOI: 10.3892/Ol.2013.1140 |
0.75 |
|
2013 |
Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, Tsai MY, Luo J, Chang C. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology (Baltimore, Md.). 57: 1550-63. PMID 23150236 DOI: 10.1002/Hep.26135 |
0.753 |
|
2013 |
Hsieh TF, Chen CC, Chang CH, Yu AL, Ma WL, Shyr CR. The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fã¼R Toxikologische Pathologie. 65: 703-8. PMID 23069010 DOI: 10.1016/j.etp.2012.09.003 |
0.684 |
|
2013 |
Shyr CR, Chen CC, Hsieh TF, Chang CH, Ma WL, Yeh S, Messing E, Li TH, Li FY, Chang C. The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine. 43: 191-9. PMID 22851332 DOI: 10.1007/S12020-012-9762-4 |
0.739 |
|
2012 |
Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md.). 56: 176-85. PMID 22318717 DOI: 10.1002/Hep.25644 |
0.796 |
|
2011 |
Hsu JW, Yasmin-Karim S, King MR, Wojciechowski JC, Mickelsen D, Blair ML, Ting HJ, Ma WL, Lee YF. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. The American Journal of Pathology. 178: 872-80. PMID 21281819 DOI: 10.1016/J.Ajpath.2010.10.036 |
0.674 |
|
2010 |
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine. 2: 32ra35. PMID 20484730 DOI: 10.1126/Scitranslmed.3001143 |
0.714 |
|
2010 |
Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene. 29: 3593-604. PMID 20440270 DOI: 10.1038/Onc.2010.121 |
0.54 |
|
2010 |
Ma W, Hsu C, Wu M, Huang C, Hsu J, Chen C, Wu C, Chang C. Abstract 2917: Novel function of androgen receptor: Cancer suppressor in hepatocellular carcinoma Cancer Research. 70: 2917-2917. DOI: 10.1158/1538-7445.Am10-2917 |
0.753 |
|
2008 |
Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135: 947-55, 955.e1-5. PMID 18639551 DOI: 10.1053/J.Gastro.2008.05.046 |
0.779 |
|
2008 |
Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology (Baltimore, Md.). 47: 1924-35. PMID 18449947 DOI: 10.1002/Hep.22252 |
0.72 |
|
2007 |
Kim E, Ma WL, Lin DL, Inui S, Chen YL, Chang C. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochemical and Biophysical Research Communications. 361: 323-8. PMID 17655826 DOI: 10.1016/J.Bbrc.2007.06.168 |
0.452 |
|
2007 |
Zheng Y, Chen WL, Ma WL, Chang C, Ou JH. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology. 363: 454-61. PMID 17335866 DOI: 10.1016/J.Virol.2007.01.040 |
0.527 |
|
2002 |
Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. The Journal of Biological Chemistry. 277: 43749-56. PMID 12226080 DOI: 10.1074/Jbc.M205603200 |
0.753 |
|
Low-probability matches (unlikely to be authored by this person) |
2018 |
Kao TL, Kuan YP, Cheng WC, Chang WC, Jeng LB, Yeh S, Ma WL. Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration. Theranostics. 8: 2672-2682. PMID 29774067 DOI: 10.7150/Thno.23624 |
0.295 |
|
2014 |
Chung WM, Chang WC, Chen L, Lin TY, Chen LC, Hung YC, Ma WL. Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells. Stem Cell Research. 13: 24-35. PMID 24793306 DOI: 10.1016/j.scr.2014.04.003 |
0.287 |
|
2019 |
Chang WC, Wang HC, Cheng WC, Yang JC, Chung WM, Ho YP, Chen L, Hung YC, Ma WL. LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity. Endocrine-Related Cancer. PMID 31815680 DOI: 10.1530/ERC-19-0095 |
0.286 |
|
2016 |
Chang WC, Huang SF, Lee YM, Lai HC, Cheng BH, Cheng WC, Yen-Ping Ho J, Jeng LB, Ma WL. Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival. Oncotarget. PMID 27893427 DOI: 10.18632/oncotarget.13524 |
0.275 |
|
2017 |
Chen L, Bao BY, Chang WC, Ho JY, Cheng BH, Wang CL, Tang Q, Cheng WC, Chang HW, Hung YC, Ma WL. Short androgen receptor poly-glutamine-promoted endometrial cancer is associated with benzo[a]pyrene-mediated aryl hydrocarbon receptor activation. Journal of Cellular and Molecular Medicine. PMID 28782227 DOI: 10.1111/jcmm.13291 |
0.27 |
|
2024 |
Wang K, Liao PY, Chang WC, Yang CR, Su YT, Wu PC, Wu YC, Hung YC, Akhtar N, Lai HC, Ma WL. Linoleate-pazopanib conjugation as active pharmacological ingredient to abolish hepatocellular carcinoma growth. Frontiers in Pharmacology. 14: 1281067. PMID 38293667 DOI: 10.3389/fphar.2023.1281067 |
0.27 |
|
2020 |
Yeh CC, Liao PY, Pandey S, Yung SY, Lai HC, Jeng LB, Chang WC, Ma WL. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology. 10: 572861. PMID 33194674 DOI: 10.3389/fonc.2020.572861 |
0.263 |
|
2014 |
Hung YC, Chang WC, Chen LM, Chang YY, Wu LY, Chung WM, Lin TY, Chen LC, Ma WL. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro. Journal of Cellular Physiology. 229: 752-61. PMID 24142535 DOI: 10.1002/jcp.24495 |
0.247 |
|
2022 |
Ma WL, Chang N, Yu Y, Su YT, Chen GY, Cheng WC, Wu YC, Li CC, Chang WC, Yang JC. Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth. Cancer Medicine. PMID 35545835 DOI: 10.1002/cam4.4536 |
0.232 |
|
2021 |
Wu FL, Chu PY, Chen GY, Wang K, Hsu WY, Ahmed A, Ma WL, Cheng WC, Wu YC, Yang JC. Natural Anthraquinone Compound Emodin as a Novel Inhibitor of Aurora A Kinase: a Pilot Study. Chemical Biology & Drug Design. PMID 34411446 DOI: 10.1111/cbdd.13938 |
0.227 |
|
2017 |
Kao TL, Chen YL, Kuan YP, Chang WC, Ho YC, Yeh S, Jeng LB, Ma WL. Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression. Cell Transplantation. 26: 1822-1829. PMID 29338386 DOI: 10.1177/0963689717738258 |
0.225 |
|
2021 |
Huang CL, Chiang YC, Chang WC, Su YT, Yang JC, Cheng WC, Lane HY, Ho IK, Ma WL. Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment. Frontiers in Endocrinology. 12: 638884. PMID 34434167 DOI: 10.3389/fendo.2021.638884 |
0.222 |
|
2018 |
Lei FJ, Cheng BH, Liao PY, Wang HC, Chang WC, Lai HC, Yang JC, Wu YC, Chu LC, Ma WL. Survival benefit of sphingosin-1-phosphate and receptors expressions in breast cancer patients. Cancer Medicine. PMID 29923327 DOI: 10.1002/cam4.1609 |
0.216 |
|
2018 |
Chang WC, Cheng WC, Cheng BH, Chen L, Ju LJ, Ou YJ, Jeng LB, Yang MD, Hung YC, Ma WL. Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. Cancer Medicine. PMID 29493120 DOI: 10.1002/cam4.1295 |
0.185 |
|
2016 |
Lee YM, Chang WC, Ma WL. Hypothesis: solid tumours behave as systemic metabolic dictators. Journal of Cellular and Molecular Medicine. PMID 26843513 DOI: 10.1111/jcmm.12794 |
0.181 |
|
2022 |
Yang CR, Liang CT, Tsai SC, Wu YC, Liu CW, Yang HH, Tu TY, Lee YC, Hsiao KY, Chang WC, Ma WL. A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids. International Journal of Molecular Sciences. 23. PMID 36430445 DOI: 10.3390/ijms232213962 |
0.175 |
|
2017 |
Chiang YC, Wang RY, Huang CL, Chen SH, Ho WJ, Lane HY, Ho IK, Yang HT, Ma WL. Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction. Journal of Cellular and Molecular Medicine. PMID 28699698 DOI: 10.1111/jcmm.13266 |
0.171 |
|
2015 |
Liu CM, Chiu KL, Chen TS, Chang SM, Yang SY, Chen LH, Ni YL, Sher YP, Yu SL, Ma WL. Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma. Biomed Research International. 2015: 642041. PMID 25692143 DOI: 10.1155/2015/642041 |
0.168 |
|
2024 |
Chu PY, Hsu CL, Lin YA, Pan YC, Dai YH, Yu YC, Yang JC, Ma WL, Chen YL, Lee CL, Wu YC. Effects of Hayata juice on high-fat diet-induced obesity in HBV transgenic mice. Heliyon. 10: e24438. PMID 38312542 DOI: 10.1016/j.heliyon.2024.e24438 |
0.167 |
|
2020 |
Chen L, Ma WL, Cheng WC, Yang JC, Wang HC, Su YT, Ahmad A, Hung YC, Chang WC. Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy. Journal of Cellular and Molecular Medicine. PMID 32543783 DOI: 10.1111/jcmm.15218 |
0.163 |
|
2022 |
Yu YC, Ahmed A, Lai HC, Cheng WC, Yang JC, Chang WC, Chen LM, Shan YS, Ma WL. Review of the endocrine organ-like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma. Frontiers in Oncology. 12: 1057930. PMID 36465353 DOI: 10.3389/fonc.2022.1057930 |
0.145 |
|
2024 |
Yang CR, Lin WJ, Shen PC, Liao PY, Dai YC, Hung YC, Lai HC, Mehmood S, Cheng WC, Ma WL. Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis. Biomarker Research. 12: 6. PMID 38195587 DOI: 10.1186/s40364-023-00555-9 |
0.142 |
|
2017 |
Wang DC, Huang JC, Lo NW, Chen LR, Mermillod P, Ma WL, Chiang HI, Ju JC. Sonic Hedgehog promotes in vitro oocyte maturation and term development of embryos in Taiwan native goats. Theriogenology. 103: 52-58. PMID 28779609 DOI: 10.1016/j.theriogenology.2017.07.029 |
0.116 |
|
2021 |
Chang CK, Cheng WC, Ma WL, Chen PK, Chen CH, Shen PC, Chen CC, Chang SH, Lai YH, Chen DY. The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis. International Journal of Molecular Sciences. 22. PMID 34768851 DOI: 10.3390/ijms222111419 |
0.105 |
|
2021 |
Lin YA, Chu PY, Ma WL, Cheng WC, Chan ST, Yang JC, Wu YC. Enzyme-Digested Peptides Derived from Enhance Wound Healing after Surgical Incision in a Murine Model. Marine Drugs. 19. PMID 33809638 DOI: 10.3390/md19030154 |
0.087 |
|
2023 |
Lee HC, Cheng WC, Ma WL, Lin YH, Shin SJ, Lin YH. Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome. Scientific Reports. 13: 6575. PMID 37085694 DOI: 10.1038/s41598-023-33757-0 |
0.064 |
|
2005 |
Chuang YC, Yang LC, Chiang PH, Kang HY, Ma WL, Wu PC, DeMiguel F, Chancellor MB, Yoshimura N. Gene gun particle encoding preproenkephalin cDNA produces analgesia against capsaicin-induced bladder pain in rats. Urology. 65: 804-10. PMID 15833551 DOI: 10.1016/j.urology.2004.10.070 |
0.055 |
|
2018 |
Lee YM, Kor CT, Zhou D, Lai HC, Chang CC, Ma WL. Impact of age at appendectomy on development of type 2 diabetes: A population-based cohort study. Plos One. 13: e0205502. PMID 30325958 DOI: 10.1371/journal.pone.0205502 |
0.053 |
|
2021 |
Lin WJ, Shen PC, Liu HC, Cho YC, Hsu MK, Lin IC, Chen FH, Yang JC, Ma WL, Cheng WC. LipidSig: a web-based tool for lipidomic data analysis. Nucleic Acids Research. PMID 34048582 DOI: 10.1093/nar/gkab419 |
0.034 |
|
Hide low-probability matches. |